平均动脉压/去甲肾上腺素等效剂量指数作为血管升压药治疗休克患者死亡风险的早期指标
本研究基于MIMIC-IV数据库开展回顾性队列研究,纳入19,539条ICU记录,按ICU入院24小时内MAP/NEQ指数三分位分组。多因素Cox分析显示高MAP/NEQ指数与死亡风险降低独立相关,MAP/NEQ指数与死亡率呈L形关联,分段回归提示MAP/NEQ指数低于183可能与死亡风险显著增加相关。该指数对7、14、21、28天死亡的ROC曲线下面积接近0.7。结论认为早期低MAP/NEQ指数提示血管升压药治疗的休克患者预后不良。
要点
- 基于MIMIC-IV数据库的19,539条ICU记录,按入院24小时内MAP/NEQ指数三分位分组,高MAP/NEQ指数与死亡风险降低独立相关。
- MAP/NEQ指数与死亡率呈L形关联,分段回归提示MAP/NEQ指数低于183可能与死亡风险显著增加相关。
- MAP/NEQ指数对7、14、21、28天死亡的ROC曲线下面积接近0.7。
- 早期低MAP/NEQ指数提示血管升压药治疗的休克患者预后不良。
适用人群与场景
- 基于MIMIC-IV数据库的ICU记录,纳入19,539条符合条件的ICU记录,均为使用血管升压药的休克患者。
诊断标准与关键阈值
- MAP/NEQ指数:平均动脉压(MAP)与去甲肾上腺素等效剂量(NEQ)的比值,计算时间为ICU入院24小时内。
- 按MAP/NEQ指数三分位分为第一三分位组、第二三分位组和第三三分位组。
- 分段回归提示MAP/NEQ指数低于183可能与死亡风险显著增加相关。
研究设计与关键结果
- 研究类型:基于MIMIC-IV数据库的回顾性队列研究,样本量19,539条ICU记录。
- 分组:按ICU入院24小时内MAP/NEQ指数三分位分为三组(第一三分位、第二三分位、第三三分位)。
- 主要结局:7天、14天、21天和28天死亡率。
- 多因素Cox分析显示高MAP/NEQ指数与死亡风险降低独立相关。
- MAP/NEQ指数对不同死亡结局的ROC曲线下面积接近0.7。
- MAP/NEQ指数与死亡结局或死亡风险呈L形关联。
- 分段回归提示MAP/NEQ指数低于183可能与死亡风险显著增加相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为早期低MAP/NEQ指数提示血管升压药治疗的休克患者预后不良。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Purpose: We aimed to investigate the association between the early mean arterial pressure (MAP)/norepinephrine equivalent dose (NEQ) index and mortality risk in patients with shock on vasopressors and further identify the breakpoint value of the MAP/NEQ index for high mortality risk. Methods: Based on the Medical Information Mart for Intensive Care IV database, we conducted a retrospective cohort study involving 19,539 eligible intensive care unit records assigned to three groups (first tertile, second tertile, and third tertile) by different MAP/NEQ indexes within 24 h of intensive care unit admission. The study outcomes were 7-, 14-, 21-, and 28-day mortality. A Cox model was used to examine the risk of mortality following different MAP/NEQ indexes. The receiving operating characteristic curve was used to evaluate the predictive ability of the MAP/NEQ index. The restricted cubic spline was applied to fit the flexible correlation between the MAP/NEQ index and risk of mortality, and segmented regression was further used to identify the breakpoint value of the MAP/NEQ index for high mortality risk. Results: Multivariate Cox analysis showed that a high MAP/NEQ index was independently associated with decreased mortality risks. The areas under the receiving operating characteristic curve of the MAP/NEQ index for different mortality outcomes were nearly 0.7. The MAP/NEQ index showed an L-shaped association with mortality outcomes or mortality risks. Exploration of the breakpoint value of the MAP/NEQ index suggested that a MAP/NEQ index less than 183 might be associated with a significantly increased mortality risk. Conclusions: An early low MAP/NEQ index was indicative of poor prognosis in patients with shock on vasopressors.
参考来源
- Yang J, Zou X, Wang R, et al. MEAN ARTERIAL PRESSURE/NOREPINEPHRINE EQUIVALENT DOSE INDEX AS AN EARLY MEASURE FOR MORTALITY RISK IN PATIENTS WITH SHOCK ON VASOPRESSORS. Shock. 2023. PMID: 38157472. doi:10.1097/SHK.0000000000002298
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。